Embed Size (px)
DESCRIPTION
Market Research Reports, Inc. has announced the addition of “Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries” research report to their offering. See more at- http://mrr.cm/ZAJ
Citation preview
www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: June 1, 2014
Number of Pages: 91
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 3,500
Price For Site License: USD 7,000
Price For Global User License: USD 10,500
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
Antihypertensive Therapeutics in Major Developed Markets to2020 Increased Uptake of Combination Therapies to OffsetEffects of Key Patent Expiries report provides in-depth analysisof hypertension therapeutics market within the eight majorgeographies of the US. The report provides an estimation ofmarket size for 2013, along with market forecast until 2020.
www.MarketResearchReports.com
Research Findings
The global anti-hypertensives market is expected todecline during the forecast period at a negativeCompound Annual Growth Rate (CAGR) of 0.9% from $40billion in 2013 to $37.6 billion in 2020, with growthexpected from 2013 to 2017 at a CAGR of 2.6% and adecline thereafter.
The initial growth will be due to the increasedpenetration of fixed-dose combination drugs (Amturnide,Exforge Tribenzor, Azor, Tekturna HCT, Edarbyclor,Twynsta, Benicar HCT, Micardis Plus, Tekamlo, Valturna), arise in the prevalence population from 181 million to 190million at a CAGR of 0.6%, and two new expectedlaunches in the pipeline (azilsartan + amlodipine, andAHU377+ valsartan).
www.MarketResearchReports.com
Research Findings Continues..
However, due to the expiry of the exclusivity of majordrugs both before and during the forecast period (Cozaarin 2010; Diovan, Avapro and Atacand in 2012; Exforge in2014; Benicar in 2016; and Tekturna and Tekturna HCT in2018), increased generic penetration and a low diagnosisrate, the market will decline from 2017.
Hypertension is a chronic disease and so its managementrequired prolonged treatment. The management ofhypertension requires prolonged treatment as it is achronic disease, ultimately ensuring market stabilitydespite generic erosion.
www.MarketResearchReports.com
Scope
Disease overview, as well as treatment algorithms andtreatment use patterns
Market size and forecast for the hypertension marketfrom 2013-2020
Major marketed products for hypertension along with aheat map of product performance
In-depth pipeline analysis for global pipeline inhypertension along with clinical trial failure rate analysis
Key drivers and restraints that have had and areexpected to have a significant impact upon the market
Key licensing and co-development agreements that couldhave impact on growth trends
www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Marketed Products
3. Product Pipeline
4. Market Forecast
5. Deals and Strategic Consolidations
6. Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research:
Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/ZAJ
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : [email protected]
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)
